摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-oxopentan-2-yl benzoate

中文名称
——
中文别名
——
英文名称
3-oxopentan-2-yl benzoate
英文别名
(2R)-2-(benzoyloxy)-3-Pentanone
3-oxopentan-2-yl benzoate化学式
CAS
——
化学式
C12H14O3
mdl
MFCD24391519
分子量
206.241
InChiKey
WENOPEBWFIDEKJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    15
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.333
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    参考文献:
    名称:
    A General Method for the α-Acyloxylation of Carbonyl Compounds
    摘要:
    A simple, one-pot method for the alpha-acyloxylation of carbonyl compounds that proceeds at room temperature in the presence of both moisture and air has been developed. Treatment of a variety of aldehydes and both cyclic and acyclic ketones with N-methyl-O-benzoylhydroxylamine hydrochloride provides the alpha-functionalized product in 69-92% isolated yield. The transformation is tolerant of a wide range of functional groups and, significantly, is reglospecific in the discrimination of secondary over primary centers in the case of nonsymmetrical substrates.
    DOI:
    10.1021/ol052474e
点击查看最新优质反应信息

文献信息

  • 1,2-Dibromoethane and KI mediated α-acyloxylation of ketones with carboxylic acids
    作者:Xujie Wang、Gangsheng Li、Yanan Yang、Jianshuang Jiang、Ziming Feng、Peicheng Zhang
    DOI:10.1016/j.cclet.2019.08.052
    日期:2020.3
    Abstract The 1,2-dibromoethane- and KI-mediated α-acyloxylation of ketones is reported in moderate to good yield without the use of transition metals and strong oxidants. Various acids are well tolerated with wide functional group compatibility. An 1,2-dibromoethane- and KI-catalysed reaction mechanism is proposed based on the results of control experiments.
    摘要据报道,在不使用过渡金属和强氧化剂的情况下,酮的1,2-二溴乙烷和KI介导的α-酰氧基化反应具有中等至良好的收率。各种酸均具有良好的耐受性,并具有广泛的官能团相容性。根据控制实验结果,提出了1,2-二溴乙烷和KI催化的反应机理。
  • Process for total synthesis of pladienolide B and pladienolide D
    申请人:Kanada Mikie Regina
    公开号:US20080021226A1
    公开(公告)日:2008-01-24
    [Problems to be Solved] To provide an effective process for total synthesis of pladienolide B and pladienolide D having excellent anti-tumor activity and to provide useful intermediates in the above-described process. [Measure for Solving the Problem] A process for producing a compound represented by Formula (11): wherein P 1 , P 7 , P 8 , P 9 and R 1 are the same as defined below, characterized by including reacting a compound represented by Formula (12): wherein P 7 means a hydrogen atom or a protecting group for hydroxy group; R 1 means a hydrogen atom or a hydroxy group, with a compound represented by Formula (13): wherein P 1 means a hydrogen atom or a protecting group for hydroxy group; P 8 means a hydrogen atom, an acetyl group or a protecting group for hydroxy group; P 9 means a hydrogen atom or a protecting group for hydroxy group; or P 8 and P 9 may form together a group represented by a formula: wherein R 5 means a phenyl group which may have a substituent, in the presence of a catalyst.
    解决的问题:提供一种有效的全合成过程,用于合成具有出色抗肿瘤活性的pladienolide B和pladienolide D,并在上述过程中提供有用的中间体。 解决问题的措施:一种制备由下式(11)表示的化合物的方法: 其中P1、P7、P8、P9和R1如下定义,其特征在于包括将由下式(12)表示的化合物与由下式(13)表示的化合物在催化剂存在下反应: 其中P7表示氢原子或羟基的保护基团;R1表示氢原子或羟基; 其中P1表示氢原子或羟基的保护基团;P8表示氢原子、乙酰基团或羟基的保护基团;P9表示氢原子或羟基的保护基团;或P8和P9可共同形成下式所示的基团: 其中R5表示可能具有取代基的苯基。
  • PROCESS FOR TOTAL SYNTHESIS OF PLADIENOLIDE B AND PLADIENOLIDE D
    申请人:KANADA Regina Mikie
    公开号:US20100204490A1
    公开(公告)日:2010-08-12
    Process for producing compound of Formula: wherein P 2 , P 3 and R 2 are the same as defined below, characterized by comprising reacting a compound represented by Formula (7): wherein P 3 means a protecting group for hydroxy group; and Het means a 1-phenyl-1H-tetrazol-5-yl group, with a compound represented by Formula (8): wherein P 2 means a protecting group for hydroxy group; and R 2 means a phenyl group which may be substituted, in the presence of a base.
    生产式子为:其中P2、P3和R2的定义如下,其特征在于通过将式子(7)所代表的化合物与式子(8)所代表的化合物在碱存在下反应,其中P3代表羟基的保护基;Het代表1-苯基-1H-四唑-5-基基团,P2代表羟基的保护基;R2代表苯基,可以被取代。
  • α-Acyloxylation of Ketones/Cyclic Ethers Mediated by Hypervalent Iodine(III) Reagents as Oxidants and Nucleophilic Sources
    作者:Hao Jia、Nan Li、Chunmei Tang、Wenjing Ni、Xinru Zhao、Jing Sun、Fufang Wu、Xiaobao Shen、Hongbin Zhai
    DOI:10.1021/acs.joc.3c02526
    日期:2024.2.2
    This study describes a catalyst-free α-acyloxylation of ketones and a KBr-mediated α-acyloxylation of cyclic ethers. These conversions are effectively mediated by hypervalent iodine(III) reagents serving dual roles as the oxidant and nucleophilic source. Consequently, esters are produced directly in moderate to excellent yields. The proposed method features good functional group compatibility, a broad
    本研究描述了酮的无催化剂 α-酰氧基化和 KBr 介导的环醚 α-酰氧基化。这些转化由具有氧化剂和亲核源双重作用的高价碘 (III) 试剂有效介导。因此,可以直接以中等至优异的产率生产酯。该方法具有官能团兼容性好、底物范围广、合成效率高、环境友好等特点。
  • TOTAL SYNTHESIS OF PLADIENOLIDE B AND PLADIENOLIDE D
    申请人:Eisai R&D Management Co., Ltd.
    公开号:EP1935893A1
    公开(公告)日:2008-06-25
    Disclosed is a process for production of a compound represented by the formula (11): [wherein P1 represents a hydrogen atom or a protective group for a hydroxyl group; P7 represents a hydrogen atom or a protective group for a hydroxyl group; P8 represents a hydrogen atom, an acetyl group or a protective group for a hydroxyl group and P9 represents a hydrogen atom or a protective group for a hydroxyl group, or P8 and P9 may together form a group represented by the formula: (where R5 represetns a phenyl group which may have a halogen atom; and R1 represetns a hydrogen atom or a hydroxyl group)]. The process comprises the step of reacting a compound represented by the formula (12): (wherein P7 and R1 are as defined above) with a compound represented by the formula (13): (wherein P1, P8, P9 and R5 are as defined above) in the presence of a catalyst.
    本发明公开了一种由式(11)代表的化合物的生产工艺: [其中 P1 代表氢原子或羟基的保护基团;P7 代表氢原子或羟基的保护基团;P8 代表氢原子、乙酰基或羟基的保护基团,P9 代表氢原子或羟基的保护基团,或 P8 和 P9 可共同形成由式(11)表示的基团: (其中 R5 代表苯基,该苯基可带有卤素原子;R1 代表氢原子或羟基)]。该工艺包括使式(12)所代表的化合物发生反应的步骤: (其中 P7 和 R1 如上定义)与式(13)所代表的化合物反应: (其中 P1、P8、P9 和 R5 如上定义)的化合物在催化剂存在下进行反应。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐